Abstracts
-
Meeting Abstract (26gaa01)
Pharmakologische Ergebnisse der GESCO-Machbarkeitsstudie: Pilotierung einer geschlechts- und gendersensiblen Primärversorgungsintervention bei Patient:innen mit chronischen, nicht tumorbedingten Schmerzen unter langfristiger Opioidtherapie
Bencheva V, Preuss J, Schmidt A, Kayser A, Weckbecker K, Kufeld N, Just J, Wiese B, Kersting C, Mortsiefer A, Thürmann P -
Meeting Abstract (26gaa02)
Participatory Development of an Intervention to Prevent Hospitalizations Due to Gastrointestinal Bleeding: A Digital Tool for Use in General Practice
Bernartz K, Claaßen S, Polat L, Picker-Huchzermeyer S, Chapidi K, Chapidi P, Dreischulte T, van den Akker M, Muth C, Puzhko S -
Meeting Abstract (26gaa03)
Socioeconomic Status and Type 2 Diabetes Mellitus – Identification of Potential Influencing Factors in the NAKO Cohort
Bößneck NL, Drebka A, Könnecke JK, Scholl AJ, Hau A, Bachmeier BE -
Meeting Abstract (26gaa04)
Outpatient antidepressant drug use in children and adolescents between 2018 and 2022 – a large claims-based study
Dörks M, Jobski K, Fassmer A, Poustka L, Cornelisse S, Bachmann C, Stahmeyer J, Meißner I, Hoffmann F -
Meeting Abstract (26gaa05)
Pflanzliche Arzneimittel bei gynäkologischen Beschwerden: Erkenntnisse aus der Real-World-Versorgung und Faktoren der Anwendung
Drebka A, Scholl AJ, Könnecke JK, Bößneck NL, Bachmeier BE -
Meeting Abstract (26gaa06)
Does consumer reporting of adverse drug reactions differ from physician and pharmacist reporting?
Dubrall D, Weal J, Schmid M, Sachs B -
Meeting Abstract (26gaa07)
Off-label drug use in paediatrics: What do we know about its prevalence and associated risks?
Eberl S, Neubert A -
Meeting Abstract (26gaa08)
Patient numbers within the AMNOG process: registry data versus routine data
Ehlert D, Abu Rajab-Conrads N, Schwalm A -
Meeting Abstract (26gaa09)
An ill for every approved pill? Changes in psychiatric diagnoses and prescriptions in adolescent girls between 2015-2023
Hach I, Langner I, Selke G, Eichler U -
Meeting Abstract (26gaa10)
Adverse events after drug administration in rare diseases – an analysis of the EudraVigilance database within the CONTRIBUTE project
Himmel J, Rottenkolber M, Bast N, Hellwig K, Kiltz U, Schmiedl S -
Meeting Abstract (26gaa11)
Health Economic Modelling in an Era of Limited Resources: Supporting Evidence-Based Healthcare Decisions
Janke FF, Hartmann M, Pietschmann K, Römer M, Bauerschlag D, Farker K, Wurschi GW -
Meeting Abstract (26gaa12)
Scale-Defined Anticholinergic Burden in Population-Based, Community, and Outpatient Settings: Preliminary Findings from an Ongoing Systematic Review
Könnecke JK, Bößneck NL, Drebka A, Scholl AJ, van den Akker M, Bachmeier BE -
Meeting Abstract (26gaa13)
Influenza vaccination rates among people aged 60 and older and among specific at-risk groups
Lappe V, Grandt D, Schubert I -
Meeting Abstract (26gaa14)
Clinical pharmacist in the emergency department: A pilot project at a German non-university hospital
Lindner S, Löffler M, von Ameln-Mayerhofer A -
Meeting Abstract (26gaa15)
Non-medical use of prescription-only medicines in Berlin’s club and party scene
Ludwig L, Rottenkolber D -
Meeting Abstract (26gaa16)
The utilization of anti-estrogenic drugs in girls and women of childbearing age and before pregnancy in Germany
Melcher N, Haug U -
Meeting Abstract (26gaa17)
Analgesic use and medication beliefs in persons with and without headache: An analysis of the Epidemiological Survey of Substance abuse in Germany (ESA 2021)
Moormann N, Hoffmann F, Bantel C, Jobski K -
Meeting Abstract (26gaa18)
Data-driven identification of multiple medication use in the German National Cohort (NAKO)
Peltner J, Wicherski J, Degen M, Ebert N, Haug U, Heier M, Linseisen J, Keil T, Haenisch B -
Meeting Abstract (26gaa19)
Measuring medication safety in primary care: a systematic review of the clinical content of 26 consensus based prescribing tools
Pohl S, Dreischulte T -
Meeting Abstract (26gaa20)
Risk of cancer among GLP-1 receptor agonist users: the impact of study design choices
Russek M, Haenisch B, Krüger N, Wang SV, Schneeweiss S -
Meeting Abstract (26gaa21)
Pharmacological Stratification of Fall-Risk-Increasing Drugs for Prevention of Fall-related Injuries in Older Adults: A Population-Based Cohort Study
Schechner M, Rottenkolber M, Oehler P, Guthrie B, Grill E, Hoffmann S, Piller J, Bender A, Dreischulte T -
Meeting Abstract (26gaa22)
Mehr Männer als Frauen und mehr in Ost als West nutzen gewichtsreduzierende Medikamente? Analyse gewichtssenkender Arzneimittel in der privaten Krankenversicherung im Zeitverlauf 2019–2023
Schneider N, Jacke C -
Meeting Abstract (26gaa23)
Prescription Status of Ginkgo biloba L. Leaf Extract and Treatment Habits in the German National Cohort
Scholl AJ, Drebka A, Könnecke JK, Bößneck NL, Bachmeier BE -
Meeting Abstract (26gaa24)
Overtreatment among levothyroxine users defined by diagnostic and prognostic thyrotropin (TSH) cut-offs: a population-based study
Scholle OHF, Ittermann T, Völzke H, Pohlabeln H, Feldkamp J, Günther K, Friedrich N, Nauck M, Krist L, Leitzmann MF, Li Y, Lieb W, Mikolajczyk R, Moreno Velásquez I, Obi N, Pischon T, Schmidt B, Schultheiss UT, Stopsack KH, Brandes B -
Meeting Abstract (26gaa25)
Community Pharmacy-Based Care in Mental Health: Current Insights from the PharmBePsych Cluster-Randomized Trial
Springer L, Kaupp M, Lietz C, Schlenk M, Lieb K, Wiegand H, Friedland K -
Meeting Abstract (26gaa26)
Medication errors in spontaneous adverse drug reaction reports: Findings from the ALERT project with a focus on device-associated contraceptives
Weal J, Sachs B, Kayser C, Dubrall D
